rs772677312

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PS3PM1

The NM_174936.4(PCSK9):​c.1399C>G​(p.Pro467Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,612,012 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000952141: Experimental studies have shown that this missense change affects PCSK9 function (PMID:26541928, 29259136).". Synonymous variant affecting the same amino acid position (i.e. P467P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

PCSK9
NM_174936.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:11

Conservation

PhyloP100: 0.496

Publications

8 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000952141: Experimental studies have shown that this missense change affects PCSK9 function (PMID: 26541928, 29259136).
PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 5 benign, 12 uncertain in NM_174936.4

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.1399C>Gp.Pro467Ala
missense
Exon 9 of 12NP_777596.2
PCSK9
NM_001407240.1
c.1522C>Gp.Pro508Ala
missense
Exon 10 of 13NP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.1399C>Gp.Pro467Ala
missense
Exon 9 of 12NP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.1399C>Gp.Pro467Ala
missense
Exon 9 of 12ENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.1756C>Gp.Pro586Ala
missense
Exon 9 of 12ENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.1522C>Gp.Pro508Ala
missense
Exon 10 of 13ENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152136
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000278
AC:
7
AN:
251378
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1459876
Hom.:
0
Cov.:
86
AF XY:
0.0000207
AC XY:
15
AN XY:
726242
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33414
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86172
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53368
Middle Eastern (MID)
AF:
0.000241
AC:
1
AN:
4144
European-Non Finnish (NFE)
AF:
0.0000216
AC:
24
AN:
1111996
Other (OTH)
AF:
0.00
AC:
0
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152136
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41452
American (AMR)
AF:
0.000262
AC:
4
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000412
AC:
5

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
2
-
Hypercholesterolemia, autosomal dominant, 3 (3)
-
3
-
not provided (3)
1
1
-
Familial hypercholesterolemia (2)
1
1
-
Hypercholesterolemia, familial, 1 (2)
-
2
-
not specified (2)
-
1
-
Cardiovascular phenotype (1)
-
1
-
Hypobetalipoproteinemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
11
DANN
Benign
0.82
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.045
D
MetaRNN
Uncertain
0.48
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
0.50
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.90
N
REVEL
Benign
0.069
Sift
Benign
0.70
T
Sift4G
Benign
0.35
T
Polyphen
0.70
P
Vest4
0.70
MutPred
0.39
Gain of MoRF binding (P = 0.0446)
MVP
0.79
MPC
0.33
ClinPred
0.078
T
GERP RS
3.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.19
gMVP
0.58
Mutation Taster
=35/65
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772677312; hg19: chr1-55524216; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.